Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_assertion type Assertion NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_head.
- NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_assertion description "[Because of tumor heterogeneity, the high number of receptors in the PC-3 line may not represent the clinical situation, and little definitive work on the GRP-R status of primary prostate tumors and metastases exists.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_provenance.
- NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_assertion evidence source_evidence_literature NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_provenance.
- NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_assertion SIO_000772 19910427 NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_provenance.
- NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_assertion wasDerivedFrom befree-20140225 NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_provenance.
- NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_assertion wasGeneratedBy ECO_0000203 NP546064.RAC7T58KCkTW-7WDGyl9M_4DGRLoVtmTDJnaJygbqV-i8130_provenance.